Ex Parte Ozeki et al - Page 5




              Appeal No. 2006-0108                                                                                                             
              Application No. 09/980,620                                                                                                       

              35 U.S.C. §103(a)                                                                                                                
                     Claims 5-14 and 16-28 stand rejected under 35 U.S.C. §103(a), as obvious over                                             
              Kakuda in view of Ekanayake.   Appellants separately argue composition claim 10, and                                             
              argue claims 12-14 and 19 as a single group.  Brief, page 4.  We select claims 10 and                                            
              12 as representative.                                                                                                            
                     According to the examiner (Answer, page 5)                                                                                
                            Kakuda [ ] as discussed above, teach a caffeine stimulation                                                        
                     inhibitor… The caffeine stimulation inhibitor is preferably used as an                                                    
                     additive of beverages and foods and may also be absorbed in the form of                                                   
                     tablets, capsules, granules or syrup (col. 2, lines 63-67). Kakuda [ ]                                                    
                     disclose various experiments and studies demonstrating the antagonistic                                                   
                     action of theanine (col. 3-5).                                                                                            
                            Kakuda [ ] is deficient only in the sense that he does not teach                                                   
                     sugars, minerals and acids in the caffeine stimulation inhibiting tea                                                     
                     composition.                                                                                                              
                                                                                                                                              
                     Claim 10 is directed to a theanine containing composition, wherein the theanine                                           
              is administered in an amount of from 50 to 100% by weight.  According to the                                                     
              specification page 5, "the preferred content of the theanine in the composition is for 5 to                                      
              100% by weight."  Therefore, it would appear that the amount of theanine in claim 10                                             
              refers to the amount of theanine in the composition and does not relate to an amount to                                          
              be administered according to body weight.  The examiner argues that, “[a]though the                                              
              specific range of theanine is not explicitly expressed in the art, it is the position of the                                     
              examiner that it is … obvious to one of ordinary skill in the art that suitable percentages                                      
              or amounts could be determined through the use of routine or manipulative                                                        
              experimentation to obtain the best possible results, as these are indeed variable                                                
              parameters.”  Answer, pages 13-14.                                                                                               
                                                           5                                                                                   













Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007